Patterson Companies, Inc. (NASDAQ: PDCO) Stock Competitors & Peer Comparison
See PDCO's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Distribution Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for PDCO and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| PDCO | $31.33 | +0.00% | 2.8B | 20.48 | $1.53 | +2.49% |
| MCK | $863.20 | +1.11% | 98.2B | 20.55 | $40.82 | +0.39% |
| COR | $319.18 | +0.66% | 61.2B | 18.35 | $17.15 | +0.76% |
| CAH | $228.91 | -2.53% | 53.5B | 21.90 | $10.43 | +0.89% |
| ABC | $179.98 | -0.23% | 36.1B | 21.92 | $8.21 | N/A |
| HSIC | $88.47 | -0.92% | 10.1B | 16.66 | $5.31 | N/A |
| PBH | $50.93 | -1.45% | 2.4B | 11.43 | $4.42 | N/A |
| OMI | $2.68 | +8.94% | 207.1M | -0.47 | -$5.69 | N/A |
| ACH | $1.24 | -6.44% | 99.9M | 1.92 | $0.68 | N/A |
| HX | $2.24 | -4.27% | 53.4M | -1.84 | -$1.22 | N/A |
Stock Comparison
McKesson Corporation (NYSE: MCK)
PDCO vs MCK Comparison August 2026
Patterson Companies, Inc. (NASDAQ: PDCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PDCO stands at 2.8B. In comparison, MCK has a market cap of 98.2B. Regarding current trading prices, PDCO is priced at $31.33 on the NASDAQ, while MCK trades at $863.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PDCO currently has a P/E ratio of 20.48, whereas MCK's P/E ratio is 20.55. In terms of profitability, PDCO's ROE is +0.18%, compared to MCK's ROE of -1.94%. Regarding short-term risk, PDCO is less volatile compared to MCK. This indicates lower risk in terms of short-term price fluctuations for PDCO.Check MCK's competition here
Cencora, Inc. (NYSE: COR)
PDCO vs COR Comparison August 2026
Patterson Companies, Inc. (NASDAQ: PDCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PDCO stands at 2.8B. In comparison, COR has a market cap of 61.2B. Regarding current trading prices, PDCO is priced at $31.33 on the NASDAQ, while COR trades at $319.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PDCO currently has a P/E ratio of 20.48, whereas COR's P/E ratio is 18.35. In terms of profitability, PDCO's ROE is +0.18%, compared to COR's ROE of +1.06%. Regarding short-term risk, PDCO is less volatile compared to COR. This indicates lower risk in terms of short-term price fluctuations for PDCO.Check COR's competition here
Cardinal Health, Inc. (NYSE: CAH)
PDCO vs CAH Comparison August 2026
Patterson Companies, Inc. (NASDAQ: PDCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PDCO stands at 2.8B. In comparison, CAH has a market cap of 53.5B. Regarding current trading prices, PDCO is priced at $31.33 on the NASDAQ, while CAH trades at $228.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PDCO currently has a P/E ratio of 20.48, whereas CAH's P/E ratio is 21.90. In terms of profitability, PDCO's ROE is +0.18%, compared to CAH's ROE of -0.60%. Regarding short-term risk, PDCO is less volatile compared to CAH. This indicates lower risk in terms of short-term price fluctuations for PDCO.Check CAH's competition here
AmerisourceBergen Corporation (NYSE: ABC)
PDCO vs ABC Comparison August 2026
Patterson Companies, Inc. (NASDAQ: PDCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PDCO stands at 2.8B. In comparison, ABC has a market cap of 36.1B. Regarding current trading prices, PDCO is priced at $31.33 on the NASDAQ, while ABC trades at $179.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PDCO currently has a P/E ratio of 20.48, whereas ABC's P/E ratio is 21.92. In terms of profitability, PDCO's ROE is +0.18%, compared to ABC's ROE of +1.06%. Regarding short-term risk, PDCO is less volatile compared to ABC. This indicates lower risk in terms of short-term price fluctuations for PDCO.Check ABC's competition here
Henry Schein, Inc. (NASDAQ: HSIC)
PDCO vs HSIC Comparison August 2026
Patterson Companies, Inc. (NASDAQ: PDCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PDCO stands at 2.8B. In comparison, HSIC has a market cap of 10.1B. Regarding current trading prices, PDCO is priced at $31.33 on the NASDAQ, while HSIC trades at $88.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PDCO currently has a P/E ratio of 20.48, whereas HSIC's P/E ratio is 16.66. In terms of profitability, PDCO's ROE is +0.18%, compared to HSIC's ROE of +0.12%. Regarding short-term risk, PDCO is less volatile compared to HSIC. This indicates lower risk in terms of short-term price fluctuations for PDCO.Check HSIC's competition here
Prestige Consumer Healthcare Inc. (NYSE: PBH)
PDCO vs PBH Comparison August 2026
Patterson Companies, Inc. (NASDAQ: PDCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PDCO stands at 2.8B. In comparison, PBH has a market cap of 2.4B. Regarding current trading prices, PDCO is priced at $31.33 on the NASDAQ, while PBH trades at $50.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PDCO currently has a P/E ratio of 20.48, whereas PBH's P/E ratio is 11.43. In terms of profitability, PDCO's ROE is +0.18%, compared to PBH's ROE of +0.09%. Regarding short-term risk, PDCO is less volatile compared to PBH. This indicates lower risk in terms of short-term price fluctuations for PDCO.Check PBH's competition here
Owens & Minor, Inc. (NYSE: OMI)
PDCO vs OMI Comparison August 2026
Patterson Companies, Inc. (NASDAQ: PDCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PDCO stands at 2.8B. In comparison, OMI has a market cap of 207.1M. Regarding current trading prices, PDCO is priced at $31.33 on the NASDAQ, while OMI trades at $2.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PDCO currently has a P/E ratio of 20.48, whereas OMI's P/E ratio is -0.47. In terms of profitability, PDCO's ROE is +0.18%, compared to OMI's ROE of +0.63%. Regarding short-term risk, PDCO is less volatile compared to OMI. This indicates lower risk in terms of short-term price fluctuations for PDCO.Check OMI's competition here
Accendra Health, Inc. (NYSE: ACH)
PDCO vs ACH Comparison August 2026
Patterson Companies, Inc. (NASDAQ: PDCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PDCO stands at 2.8B. In comparison, ACH has a market cap of 99.9M. Regarding current trading prices, PDCO is priced at $31.33 on the NASDAQ, while ACH trades at $1.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PDCO currently has a P/E ratio of 20.48, whereas ACH's P/E ratio is 1.92. In terms of profitability, PDCO's ROE is +0.18%, compared to ACH's ROE of +0.63%. Regarding short-term risk, PDCO is less volatile compared to ACH. This indicates lower risk in terms of short-term price fluctuations for PDCO.Check ACH's competition here
Akso Health Group (NASDAQ: HX)
PDCO vs HX Comparison August 2026
Patterson Companies, Inc. (NASDAQ: PDCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PDCO stands at 2.8B. In comparison, HX has a market cap of 53.4M. Regarding current trading prices, PDCO is priced at $31.33 on the NASDAQ, while HX trades at $2.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PDCO currently has a P/E ratio of 20.48, whereas HX's P/E ratio is -1.84. In terms of profitability, PDCO's ROE is +0.18%, compared to HX's ROE of -1.07%. Regarding short-term risk, PDCO is less volatile compared to HX. This indicates lower risk in terms of short-term price fluctuations for PDCO.Check HX's competition here
111, Inc. (NASDAQ: YI)
PDCO vs YI Comparison August 2026
Patterson Companies, Inc. (NASDAQ: PDCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PDCO stands at 2.8B. In comparison, YI has a market cap of 29.8M. Regarding current trading prices, PDCO is priced at $31.33 on the NASDAQ, while YI trades at $3.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PDCO currently has a P/E ratio of 20.48, whereas YI's P/E ratio is -2.44. In terms of profitability, PDCO's ROE is +0.18%, compared to YI's ROE of +0.14%. Regarding short-term risk, PDCO is less volatile compared to YI. This indicates lower risk in terms of short-term price fluctuations for PDCO.Check YI's competition here
Wellgistics Health, Inc. (NASDAQ: WGRX)
PDCO vs WGRX Comparison August 2026
Patterson Companies, Inc. (NASDAQ: PDCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PDCO stands at 2.8B. In comparison, WGRX has a market cap of 8.7M. Regarding current trading prices, PDCO is priced at $31.33 on the NASDAQ, while WGRX trades at $3.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PDCO currently has a P/E ratio of 20.48, whereas WGRX's P/E ratio is -0.33. In terms of profitability, PDCO's ROE is +0.18%, compared to WGRX's ROE of +8.78%. Regarding short-term risk, PDCO is less volatile compared to WGRX. This indicates lower risk in terms of short-term price fluctuations for PDCO.Check WGRX's competition here
ZeroStack Corp. (NASDAQ: ZSTK)
PDCO vs ZSTK Comparison August 2026
Patterson Companies, Inc. (NASDAQ: PDCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PDCO stands at 2.8B. In comparison, ZSTK has a market cap of 6.2M. Regarding current trading prices, PDCO is priced at $31.33 on the NASDAQ, while ZSTK trades at $5.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PDCO currently has a P/E ratio of 20.48, whereas ZSTK's P/E ratio is -0.12. In terms of profitability, PDCO's ROE is +0.18%, compared to ZSTK's ROE of -3.82%. Regarding short-term risk, PDCO is less volatile compared to ZSTK. This indicates lower risk in terms of short-term price fluctuations for PDCO.Check ZSTK's competition here
DataMEDS AI, Inc. (NASDAQ: MEDS)
PDCO vs MEDS Comparison August 2026
Patterson Companies, Inc. (NASDAQ: PDCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PDCO stands at 2.8B. In comparison, MEDS has a market cap of 3.8M. Regarding current trading prices, PDCO is priced at $31.33 on the NASDAQ, while MEDS trades at $1.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PDCO currently has a P/E ratio of 20.48, whereas MEDS's P/E ratio is N/A. In terms of profitability, PDCO's ROE is +0.18%, compared to MEDS's ROE of +8.78%. Regarding short-term risk, PDCO is less volatile compared to MEDS. This indicates lower risk in terms of short-term price fluctuations for PDCO.Check MEDS's competition here
Zynex, Inc. (NASDAQ: ZYXI)
PDCO vs ZYXI Comparison August 2026
Patterson Companies, Inc. (NASDAQ: PDCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PDCO stands at 2.8B. In comparison, ZYXI has a market cap of 3.8M. Regarding current trading prices, PDCO is priced at $31.33 on the NASDAQ, while ZYXI trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PDCO currently has a P/E ratio of 20.48, whereas ZYXI's P/E ratio is -0.05. In terms of profitability, PDCO's ROE is +0.18%, compared to ZYXI's ROE of +11.38%. Regarding short-term risk, PDCO is similarly volatile compared to ZYXI. This indicates similar risk in terms of short-term price fluctuations for PDCO.Check ZYXI's competition here
Synergy CHC Corp. (NASDAQ: SNYR)
PDCO vs SNYR Comparison August 2026
Patterson Companies, Inc. (NASDAQ: PDCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PDCO stands at 2.8B. In comparison, SNYR has a market cap of 1.2M. Regarding current trading prices, PDCO is priced at $31.33 on the NASDAQ, while SNYR trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PDCO currently has a P/E ratio of 20.48, whereas SNYR's P/E ratio is -0.08. In terms of profitability, PDCO's ROE is +0.18%, compared to SNYR's ROE of +0.91%. Regarding short-term risk, PDCO is less volatile compared to SNYR. This indicates lower risk in terms of short-term price fluctuations for PDCO.Check SNYR's competition here
Ridgetech, Inc. (NASDAQ: RDGT)
PDCO vs RDGT Comparison August 2026
Patterson Companies, Inc. (NASDAQ: PDCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PDCO stands at 2.8B. In comparison, RDGT has a market cap of 724.3K. Regarding current trading prices, PDCO is priced at $31.33 on the NASDAQ, while RDGT trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PDCO currently has a P/E ratio of 20.48, whereas RDGT's P/E ratio is -0.01. In terms of profitability, PDCO's ROE is +0.18%, compared to RDGT's ROE of -0.04%. Regarding short-term risk, PDCO is less volatile compared to RDGT. This indicates lower risk in terms of short-term price fluctuations for PDCO.Check RDGT's competition here
Covetrus, Inc. (NASDAQ: CVET)
PDCO vs CVET Comparison August 2026
Patterson Companies, Inc. (NASDAQ: PDCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PDCO stands at 2.8B. In comparison, CVET has a market cap of 0. Regarding current trading prices, PDCO is priced at $31.33 on the NASDAQ, while CVET trades at $20.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PDCO currently has a P/E ratio of 20.48, whereas CVET's P/E ratio is -69.97. In terms of profitability, PDCO's ROE is +0.18%, compared to CVET's ROE of -0.06%. Regarding short-term risk, PDCO is less volatile compared to CVET. This indicates lower risk in terms of short-term price fluctuations for PDCO.Check CVET's competition here